As of the latest SEC filings, NEUROCRINE BIOSCIENCES INC (NBIX) is held by 598 institutional funds. The largest fund shareholder is Dodge & Cox Stock Fund (DODGX), holding an estimated $522,217,360.00 in market value, representing 0.46% of its portfolio.
Funds holding NEUROCRINE BIOSCIENCES INC (NBIX)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- NBIX
- CIK:
- 0000914475
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
DODGX
Dodge & Cox Stock Fund
|
MF | Independent / Boutique | 0.46% | $522,217,360.00 | 3,964,000 | Mar 31, 2026 | Jun 1, 2026 |
|
IJH
iShares Core S&P Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.41% | $437,218,975.48 | 3,318,802 | Mar 31, 2026 | May 26, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.02% | $421,080,035.04 | 3,196,296 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.19% | $304,863,090.98 | 2,314,127 | Mar 31, 2026 | May 28, 2026 |
|
JGACX
JPMorgan Growth Advantage Fund
|
MF | JPMorgan | 0.86% | $174,339,578.14 | 1,323,361 | Mar 31, 2026 | May 29, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.44% | $170,578,269.40 | 1,294,810 | Mar 31, 2026 | May 28, 2026 |
|
OSGIX
JPMorgan Mid Cap Growth Fund
|
MF | JPMorgan | 1.39% | $159,043,510.22 | 1,207,253 | Mar 31, 2026 | May 29, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.18% | $147,603,867.32 | 1,120,418 | Mar 31, 2026 | May 28, 2026 |
|
MDY
SPDR S&P MidCap 400 ETF Trust
|
ETF | State Street (SPDR) | 0.41% | $99,654,459.52 | 756,448 | Mar 31, 2026 | Jun 1, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 1.18% | $95,841,113.48 | 727,502 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.16% | $86,163,756.56 | 654,044 | Mar 31, 2026 | May 28, 2026 |
|
IJK
iShares S&P Mid-Cap 400 Growth ETF
|
ETF | BlackRock / iShares | 0.81% | $80,415,545.14 | 610,411 | Mar 31, 2026 | May 28, 2026 |
|
VFLO
VictoryShares Free Cash Flow ETF
|
ETF | Independent / Boutique | 1.30% | $80,092,782.14 | 607,961 | Mar 31, 2026 | May 28, 2026 |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
ETF | First Trust | 3.45% | $78,243,811.24 | 593,926 | Mar 31, 2026 | May 28, 2026 |
|
IWP
iShares Russell Mid-Cap Growth ETF
|
ETF | BlackRock / iShares | 0.39% | $73,348,089.36 | 556,764 | Mar 31, 2026 | May 28, 2026 |
|
USMV
iShares MSCI USA Min Vol Factor ETF
|
ETF | BlackRock / iShares | 0.31% | $69,816,437.46 | 530,238 | Apr 30, 2026 | Jun 25, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.17% | $69,001,834.25 | 521,753 | Feb 28, 2026 | Apr 24, 2026 |
|
SPMD
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF
|
ETF | State Street (SPDR) | 0.41% | $64,590,541.12 | 490,288 | Mar 31, 2026 | May 28, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.27% | $59,849,808.48 | 454,544 | Apr 30, 2026 | Jun 26, 2026 |
|
VHCAX
VANGUARD CAPITAL OPPORTUNITY FUND
|
MF | Vanguard | 0.22% | $54,975,102.00 | 417,300 | Mar 31, 2026 | May 28, 2026 |
|
IWR
iShares Russell Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.10% | $48,653,953.32 | 369,318 | Mar 31, 2026 | May 28, 2026 |
|
FSMDX
Fidelity Mid Cap Index Fund
|
MF | Fidelity | 0.09% | $47,230,819.02 | 358,706 | Apr 30, 2026 | Jun 26, 2026 |
|
QLENX
AQR Long-Short Equity Fund
|
MF | Independent / Boutique | 0.57% | $46,087,658.12 | 349,838 | Mar 31, 2026 | May 22, 2026 |
|
IWF
iShares Russell 1000 Growth ETF
|
ETF | BlackRock / iShares | 0.04% | $44,012,357.90 | 334,085 | Mar 31, 2026 | May 22, 2026 |
|
-
JNL/JPMorgan MidCap Growth Fund
|
ETF | Independent / Boutique | 1.40% | $43,740,973.50 | 332,025 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)